Development and validation of a novel paediatric weight estimation equation in multinational cohorts of sick children

Lindsey McVey1, David Young2, Jessie Hulst3

  • 1Human Nutrition, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.

Resuscitation
|May 4, 2017
PubMed

Insights

Accurate weight estimation for sick children is crucial. New Children's European Estimator of Weight (CEEW) equations, using mid-upper arm circumference, show superior accuracy compared to existing methods.

Area of Science:

  • Pediatric medicine
  • Clinical assessment
  • Biostatistics

Background:

  • Accurate weight estimation is vital for administering medication and fluid to sick children who cannot be weighed.
  • Existing weight estimation equations often lack the necessary accuracy and precision for clinical use.

Purpose of the Study:

  • To develop a novel, accurate weight estimation equation for sick children in Europe.
  • To validate the new equation against established methods.

Main Methods:

  • Developed weight estimation equations using data from 2086 sick children across the UK, Greece, and the Netherlands.
  • Utilized mid-upper arm circumference (MUAC), demographics, and height measurements.
  • Compared the novel Children's European Estimator of Weight (CEEW) equations against ERC, APLS, and Cattermole equations.

Main Results:

  • Two CEEW equations (CEEW1 with height, CEEW2 without) were developed, incorporating age, gender, and MUAC.
  • Both CEEW equations demonstrated high coefficients of determination (R² > 96.5%) and minimal prediction error.
  • CEEW1 achieved 88% accuracy within 15% of measured weight, significantly outperforming comparator equations (max 57%).

Conclusions:

  • The CEEW equations offer substantially improved accuracy for weight estimation in sick children compared to current standards.
  • The developed equations provide a more reliable tool for clinical practice.
  • A mobile application for CEEW is available.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340